Vittal Vasista - 13 Jul 2022 Form 4 Insider Report for REGENXBIO Inc. (RGNX)

Role
Chief Financial Officer
Signature
/s/ Patrick J. Christmas as attorney-in-fact
Issuer symbol
RGNX
Transactions as of
13 Jul 2022
Net transactions value
-$144,028
Form type
4
Filing time
15 Jul 2022, 16:18:49 UTC
Previous filing
24 Jan 2022
Next filing
03 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGNX Common Stock Sale $129,988 -4,332 -2.7% $30.01 158,108 13 Jul 2022 Direct F1, F2
transaction RGNX Common Stock Sale $14,040 -468 -0.3% $30.00 157,640 14 Jul 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan.
F2 This transaction was executed in multiple trades at prices ranging from $30.0000 to $30.0065. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.